Red & Near-Infrared Light TherapyHealing Light. Real Results.
Photobiomodulation (PBM) harnesses specific wavelengths of red and near-infrared light to stimulate cellular repair, reduce inflammation, and accelerate healing — without drugs, needles, or downtime. Now offered at UPC Regenerative Medicine for pain, fibromyalgia, skin rejuvenation, and hair restoration.
What Is Red Light Therapy?
Red light therapy — formally known as Photobiomodulation (PBM) or Low-Level Laser/Light Therapy (LLLT) — uses specific wavelengths of red and near-infrared light to stimulate biological processes at the cellular level. Unlike UV light (which can damage DNA) or high-powered lasers (which heat and cut tissue), therapeutic light is non-thermal, non-ionizing, and works entirely through photochemical mechanisms.
The primary cellular target is cytochrome c oxidase (CCO), an enzyme in the mitochondrial respiratory chain. When photons of the right wavelength are absorbed by CCO, they trigger a cascade of beneficial effects: increased ATP production, improved oxygen utilization, upregulated antioxidant defenses, and a shift toward cellular repair and regeneration.
Different wavelengths penetrate to different tissue depths and engage different biological targets — which is why clinical protocols are matched to specific conditions and treatment depths.
Key principle: PBM is dose-dependent. The right wavelength at the right dose produces therapeutic benefit. Too little has no effect; too much can paradoxically inhibit — a phenomenon called the biphasic dose response. This is why medical-grade devices and physician oversight matter.
| Wavelength | Penetration | Primary Applications |
|---|---|---|
| 630–660 nm Visible Red |
2–3 mm Skin surface |
Collagen synthesis, wound healing, skin rejuvenation, superficial hair follicle stimulation, acne |
| 810–830 nm Near-Infrared |
3–5 cm Deep tissue |
Musculoskeletal pain, joint inflammation, nerve regeneration, deep tissue healing, brain/neuroprotection |
| 850–905 nm Near-Infrared |
5–10 cm Deep penetration |
Joint and bone conditions, spinal applications, systemic whole-body effects, fibromyalgia |
The Cellular Mechanisms of Photobiomodulation
PBM does not heat tissue or produce ionizing radiation. Its effects are entirely photochemical — light triggers a biological cascade that shifts cells from a state of stress and dysfunction toward repair and regeneration.
Mitochondrial Activation & ATP Production
Red and near-infrared photons are absorbed by cytochrome c oxidase (Complex IV) in the mitochondrial electron transport chain. This absorption dissociates inhibitory nitric oxide (NO) from CCO, restoring and enhancing mitochondrial respiration. The result is a significant increase in ATP (cellular energy) production — up to 200% in some studies — which fuels cellular repair, protein synthesis, and tissue regeneration in metabolically stressed cells.
Anti-inflammatory Effects & Cytokine Modulation
PBM reduces production of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and prostaglandins while simultaneously upregulating anti-inflammatory mediators. It improves microcirculation and lymphatic flow, reducing edema and clearing algogenic (pain-producing) metabolites. Reactive oxygen species (ROS) are transiently increased to act as second messengers that activate protective gene expression — a controlled signaling effect rather than oxidative damage.
Collagen Synthesis & Tissue Remodeling
PBM stimulates fibroblast proliferation and increases expression of collagen Type I and III — the structural proteins that give skin its firmness, joints their resilience, and tendons their strength. This collagen-stimulating effect is the basis of PBM's applications in skin rejuvenation, wound healing, tendon repair, and hair follicle health. Elastin production is also upregulated, contributing to improved skin elasticity and reduced wrinkle depth.
Neurobiological Effects & Pain Modulation
PBM modulates nociceptive (pain) signaling through multiple pathways: reducing peripheral sensitization by downregulating substance P and CGRP; modulating central pain processing via descending inhibitory pathways; and promoting endorphin release. These mechanisms make PBM uniquely effective for both peripheral and centrally mediated chronic pain — including the central sensitization underlying fibromyalgia.
Hair Follicle Stimulation
In hair follicles, PBM stimulates stem cells in the bulge region, prolongs the anagen (growth) phase, and prevents premature entry into the telogen (resting) phase. ATP production in follicle cells increases, DHT-induced follicle miniaturization is partially counteracted, and microcirculation to the follicle is improved. The FDA has cleared LLLT devices specifically for androgenic alopecia based on this evidence.
Systemic & Whole-Body Effects
When delivered to large body surface areas, PBM exerts systemic effects beyond the local treatment zone. Circulating blood absorbs photons (particularly from 630–660 nm devices), allowing light-activated nitric oxide, improved erythrocyte function, and systemic anti-inflammatory mediator changes to travel throughout the body. Whole-body PBM systems leverage this for fibromyalgia, chronic fatigue, and systemic inflammatory conditions.
Chronic Pain Management
Photobiomodulation has an emerging and compelling evidence base for chronic pain. A 2025 systematic review published in Frontiers in Integrative Neuroscience analyzed 14 RCTs across diverse chronic pain populations and found meaningful pain reduction across multiple conditions. The mechanism is well-characterized: PBM reduces peripheral sensitization, modulates central pain processing, and decreases the neuroinflammation that amplifies chronic pain signals.
Near-infrared wavelengths (810–905 nm) penetrate 5–10 cm, reaching joints, nerve tissue, and deep muscle — making PBM effective for conditions that are otherwise difficult to treat without systemic medications or invasive procedures.
A key advantage of PBM over medications is its absence of systemic side effects, drug interactions, or addiction potential. It can be used safely and repeatedly as a standalone treatment or alongside other regenerative therapies such as PRP, ketamine, or LDN.
Knee Osteoarthritis
2024 systematic review of 10 studies confirms significant pain reduction at rest vs. sham
Neck & Shoulder Pain
RCT evidence supports significant improvement in chronic neck/shoulder pain
Low Back Pain
Cochrane review and meta-analyses support LLLT for non-specific chronic low back pain
Diabetic Neuropathy
Multiple RCTs demonstrate pain reduction and functional improvement
Temporomandibular Pain
Strong RCT evidence for TMD pain and jaw function improvement
Post-Surgical Pain
Pre-emptive PBM reduces pain and inflammation following dental and orthopedic procedures
Fibromyalgia
Fibromyalgia is arguably the condition with the strongest evidence base for PBM within chronic pain. Five of the 14 RCTs in the 2025 Frontiers systematic review specifically addressed fibromyalgia — more than any other single condition. Multiple studies have demonstrated significant reductions in pain, tender point counts, fatigue, sleep disturbance, and quality-of-life impairment.
A 2023 study administering whole-body PBM via the NovoTHOR system (12 sessions at 660–850 nm over 4 weeks) found SF-36 quality-of-life scores improved from 38.1 to 55.4 (p < 0.001) — a clinically meaningful 45% improvement that persisted at 2-week follow-up. Separately, Navarro-Ledesma et al. (2022) demonstrated that whole-body PBM improved Fibromyalgia Impact Questionnaire Revised (FIQR) scores from 62.5 to 47.3 (p < 0.001).
PBM is also highly complementary to our other fibromyalgia therapies — particularly LDN (which targets neuroinflammation) and ketamine infusion (which resets central sensitization). A multi-modal approach addressing different pathways simultaneously may produce the greatest benefit.
Synergy with LDN & Ketamine: PBM, LDN, and ketamine infusion work through different mechanisms on the same underlying problem — central sensitization and neuroinflammation. Combining these therapies may produce additive or synergistic benefit for fibromyalgia patients.
Skin Rejuvenation & Aesthetics
Red light at 630–660 nm penetrates the dermis and directly stimulates fibroblasts — the cells responsible for producing collagen and elastin. Multiple RCTs and controlled trials have demonstrated measurable improvements in skin texture, wrinkle depth, firmness, and radiance following a course of PBM treatments.
A landmark controlled trial by Wunsch & Matuschka (2014) using 633 nm and 830 nm LED wavelengths found significant improvements in fine lines, wrinkle depth, skin roughness, and intradermal collagen density — confirmed by profilometry and skin biopsy. Participants and blinded investigators both rated significant improvement vs. control.
Beyond anti-aging, PBM reduces inflammation-driven skin conditions (acne, rosacea, psoriasis) and accelerates wound healing and scar remodeling. A 2024 JAAD (Journal of the American Academy of Dermatology) CME publication summarized the growing dermatological evidence base, noting that PBM is increasingly integrated into evidence-based dermatology practice.
Fine Lines & Wrinkles
RCT-confirmed reduction in wrinkle depth and roughness via collagen upregulation at 630–660 nm
Skin Firmness & Elasticity
Elastin synthesis stimulation improves skin laxity and overall tone
Hyperpigmentation & Sun Damage
PBM reduces melanin irregularity and accelerates turnover of damaged skin cells
Acne & Acne Scarring
Anti-inflammatory and sebum-modulating effects reduce active breakouts; PBM promotes scar remodeling
Rosacea & Skin Redness
Vascular and anti-inflammatory effects reduce diffuse redness and capillary dilation
Wound Healing & Scars
Accelerates wound closure, reduces scar hypertrophy, and promotes normal collagen deposition
Psoriasis & Eczema
Anti-inflammatory effects reduce plaque activity and symptom severity in inflammatory skin conditions
Overall Radiance & Glow
Improved microcirculation and cellular metabolism enhance skin luminosity and color evenness
Hair Restoration
Low-level laser/light therapy (LLLT) for androgenic alopecia (AGA) is one of the most robustly evidence-supported applications of PBM, with FDA clearance for both male and female pattern hair loss. Unlike minoxidil (which requires continuous use and causes shedding when stopped) and finasteride (with its systemic hormonal effects), LLLT is non-systemic, safe, and has no significant drug interactions.
A 2020 meta-analysis in Lasers in Surgery and Medicine analyzing seven RCTs found LLLT produced a statistically significant mean increase of 17.2 hairs/cm² compared to sham — a meaningful improvement in hair density. A 2025 review in the Journal of Cutaneous and Aesthetic Surgery confirmed that 675 nm wavelengths specifically enhance hair density by extending the anagen (growth) phase and stimulating collagen production around follicles.
LLLT works synergistically with other hair restoration approaches — it can be combined with PRP scalp injections, minoxidil, or finasteride for patients seeking maximum density restoration. Our physician will evaluate your pattern of hair loss and recommend an individualized protocol.
Male Pattern Baldness (AGA)
FDA-cleared indication. Multiple RCTs confirm increased hair count and density
Female Pattern Hair Loss
FDA-cleared. Effective for diffuse thinning and vertex pattern loss in women
Telogen Effluvium
Stress- or illness-triggered shedding responds well to PBM-mediated follicle reactivation
Post-PRP Enhancement
PBM accelerates follicle response when combined with PRP scalp injection protocols
What Can Red Light Therapy Treat?
PBM has one of the broadest potential indication lists of any non-pharmacologic therapy. The conditions below have published clinical evidence — ranging from case series to RCTs.
Fibromyalgia
5 RCTs — strongest chronic pain evidence. Pain, tender points, QoL, and function all show improvement.
Knee Osteoarthritis
2024 systematic review of 10 studies confirms significant pain reduction at rest vs. sham PBM.
Low Back Pain
Cochrane review and multiple meta-analyses support LLLT for chronic non-specific low back pain.
Neck & Shoulder Pain
RCT evidence for significant improvement in chronic cervical and shoulder pain syndromes.
Diabetic Peripheral Neuropathy
Multiple RCTs demonstrate meaningful pain reduction and potential nerve regeneration.
Chemotherapy Neuropathy
PBM reduces CIPN symptom severity by 32–53% in published trials — a critical unmet need.
Temporomandibular Disorders
Strong RCT evidence for pain reduction and improved jaw function in TMD.
Androgenic Alopecia
FDA-cleared. 7-RCT meta-analysis: +17.2 hairs/cm² vs. sham in male and female pattern loss.
Skin Aging / Wrinkles
RCT-confirmed collagen density increase and wrinkle reduction with 630–660 nm + 830 nm.
Acne Vulgaris
Anti-inflammatory and antimicrobial effects reduce active lesions and post-inflammatory erythema.
Rosacea & Sensitive Skin
Anti-vascular and anti-inflammatory effects reduce diffuse facial redness without irritation.
Wound Healing
One of the longest-established PBM applications — accelerates healing from surgery, injury, and ulcers.
Your Treatment Protocol
PBM is a cumulative therapy — results build over a series of sessions. The protocol is entirely non-invasive, painless, and requires no downtime.
Consultation
Physician evaluation of your condition, goals, and suitability. Protocol designed and wavelengths selected.
Initial Series
Most protocols: 6–12 sessions, 2–3 times per week. Each session 10–30 minutes depending on indication.
During Session
Relax while the device delivers calibrated light. No heat, no pain, no discomfort. Many patients feel a gentle warmth.
Maintenance
Many patients benefit from ongoing monthly sessions to sustain results, particularly for pain, hair, and skin.
Results timeline: Skin and pain improvements often begin within 2–4 sessions. Fibromyalgia and hair growth require longer protocols — most patients see meaningful hair density change at 3–6 months. Full results for pain conditions typically emerge over 6–12 sessions.
Benefits & Safety Considerations
Why PBM Is Exceptionally Well-Tolerated
Contraindications & Precautions
Key Published Evidence
The following peer-reviewed publications represent landmark evidence for PBM across its major clinical applications.
PBM for Chronic Pain — Systematic Review of 14 RCTs | Frontiers Integrative Neuroscience 2025
Comprehensive systematic review of all available RCTs on PBM in chronic pain. Covered fibromyalgia (5 studies), TMD (2), diabetic neuropathy (2), chemotherapy neuropathy (2), neck pain (1), post-COVID pain (1), and leprosy neuropathy (1). Significant pain reductions reported across multiple conditions with favorable safety profiles.
View Full Text (PMC)PBM in Fibromyalgia — Systematic Review (n=857) | Applied Sciences 2025
PRISMA-compliant systematic review of 17 eligible studies involving 857 fibromyalgia participants. Whole-body PBM using NovoTHOR® (660–850 nm, 12 sessions) improved SF-36 QoL scores from 38.1 to 55.4 (p < 0.001). FIQR improved from 62.5 to 47.3 (p < 0.001) in Navarro-Ledesma et al. 2022 arm. Ribeiro et al. 2023 demonstrated marked decrease in tender point counts (p < 0.0001).
View Full Text (MDPI)Red & NIR Light for Skin Rejuvenation — Controlled Trial | Photomed Laser Surg 2014
Wunsch & Matuschka. Controlled trial demonstrating efficacy of 633 nm + 830 nm LED therapy for reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase. Both participant self-assessment and blinded investigator scoring confirmed significant improvement vs. control. This remains one of the most cited RCTs in aesthetic PBM.
View Full Text (PMC)PBM in Dermatology — Clinical Applications CME | JAAD 2024
Journal of the American Academy of Dermatology CME Part II on photobiomodulation's clinical applications in dermatology. Reviews evidence for skin rejuvenation, collagen induction, wound healing, acne, rosacea, and psoriasis. Supports integration of PBM into evidence-based dermatological practice.
View Abstract (JAAD)LLLT for Androgenetic Alopecia — Meta-analysis 7 RCTs | Lasers Surg Med 2020
Meta-analysis of 7 randomized controlled trials of LLLT for androgenic alopecia found a statistically significant mean increase of 17.2 hairs/cm² compared to sham treatment. Effect was consistent across male and female pattern hair loss and across device types (helmet, comb, cap). FDA clearance for AGA is supported by this evidence base.
View Related PMC ReviewLLLT for Low Back Pain — Cochrane Systematic Review
Cochrane Database systematic review (Yousefi-Nooraie et al.) of LLLT for non-specific low back pain. Concluded that LLLT reduces pain and disability in LBP. Supported by a subsequent systematic review and meta-analysis (Huang et al., Arthritis Research & Therapy) confirming effectiveness for chronic non-specific low back pain vs. sham.
View on PubMedSession Pricing
All sessions are 20 minutes with medical-grade photobiomodulation equipment calibrated to therapeutic wavelengths and dosing parameters. No hidden fees — pricing is straightforward.
Single Session
- 20 minutes of calibrated red & near-infrared light
- Medical-grade device — validated wavelengths & dosing
- Physician-supervised protocol
- Flexible scheduling — no commitment required
- Suitable for any single indication
6-Session Package
- 6 sessions over 3 weeks — optimal treatment frequency
- Twice-weekly schedule for cumulative therapeutic benefit
- All single-session inclusions included
- Mid-package response check with physician
- Recommended starting protocol for pain, fibromyalgia & hair
- $120 savings vs. individual session pricing
Additional packages and maintenance plans available — ask at your consultation.
Red light therapy is generally not covered by health insurance. HSA/FSA cards may be accepted — please inquire.
Ready to Experience the Benefits of Red Light Therapy?
Schedule a consultation with our physician to discuss whether photobiomodulation is right for your goals — whether pain relief, skin rejuvenation, or hair restoration.
Book My ConsultationMedical Disclaimer: Photobiomodulation therapy (red light / near-infrared therapy) is a non-invasive treatment with a growing clinical evidence base. Results vary between individuals and are not guaranteed. This page is for informational purposes only and does not constitute medical advice. Candidacy is evaluated on an individual basis following consultation. All peer-reviewed references link to publicly available abstracts or full texts and are provided for informational purposes only.
